Ajanta Pharma has informed that it enclosed revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 15, 2023 for Ravi Agrawal, trustee Ravi Agrawal Trust.
The above information is a part of company’s filings submitted to BSE.